2022
DOI: 10.1016/j.compstruct.2022.115593
|View full text |Cite
|
Sign up to set email alerts
|

Robust topology optimization of biodegradable composite structures under uncertain degradation rates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…For instance, it is usually required that bone scaffolds have a slow degradation in the early stage to maintain the high mechanical strength and then fast degradation . Alternatively, when the condition of a patient treated with the citrate-based drug-eluting stent (DES) suddenly deteriorates, there is an urgent need to accelerate the degradation of the matrix to quickly release the drug for inhibition, or perhaps after finishing a given task, the citrate-based bioelectronic devices are required to be rapidly degraded to avoid the risks to the body due to their long-term retention . Notably, the degradation rates of these biodegradable implants highly depend on their matrix materials (citrate-based polymers) generally. However, the existing citrate-based polymers can only be degraded passively, resulting in these fabricated citrate-based implants hardly being regulated to their degradation rates as required during clinical applications.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, it is usually required that bone scaffolds have a slow degradation in the early stage to maintain the high mechanical strength and then fast degradation . Alternatively, when the condition of a patient treated with the citrate-based drug-eluting stent (DES) suddenly deteriorates, there is an urgent need to accelerate the degradation of the matrix to quickly release the drug for inhibition, or perhaps after finishing a given task, the citrate-based bioelectronic devices are required to be rapidly degraded to avoid the risks to the body due to their long-term retention . Notably, the degradation rates of these biodegradable implants highly depend on their matrix materials (citrate-based polymers) generally. However, the existing citrate-based polymers can only be degraded passively, resulting in these fabricated citrate-based implants hardly being regulated to their degradation rates as required during clinical applications.…”
Section: Introductionmentioning
confidence: 99%